Merz Pharma is an independent international aesthetics and neurotoxin company with its own research and development capabilities. Our continued growth and market leadership in aesthetics and neurotoxins is the result of our drive for innovation, along with focused, strategic acquisitions. We have continued to expand across all areas of our business, due to a focused, purposeful approach that includes both organic and inorganic growth. As a privately-held and family-owned company with a 100 year-plus history, we believe in taking a long-term view. Merz brings an unwavering focus to the specialties we serve, combined with a flexible, responsive approach to the individualized needs of our physician customers and their patients.
The shareholder´s council of Merz GmbH & Co. KGaA accompanies operational business of Merz.